Last edition
News about "EMA Approval "
Duke Street Bio Gets EMA Approval to Launch PARP1-Selective Inhibitor Trial
This potentially best-in-class, potent, highly selective and CNS-penetrant agent targets cancers that harbour homologous recombination deficiencies (HRD) including BRCA mutations.
EMA Approval | 25/09/2024 | By Aishwarya | 130
Biocon Biologics Gets EMA Approval for Bevacizumab and its New mAbs Facility in India
Biocon Biologics Ltd. has received approval from the European Medicines Agency (EMA) to manufacture biosimilar Bevacizumab at its new, world-class, multi-product monoclonal antibodies (mAbs) drug substance facility in Bengaluru.
EMA Approval | 24/06/2024 | By Aishwarya | 344
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy